12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Allergy Therapeutics, Paladin sales and marketing update

Paladin acquired exclusive Canadian distribution and commercialization rights for Pollinex-R ragweed vaccine from Allergy. The subcutaneous vaccine formulated with allergoids and tyrosine is...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >